BioCatalystWatch
ETONWorkspace / ETON / OverviewCompany library
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc. (ETON)

Website

Price
Market cap
Next catalystExpected 2H 2026ET-800 · Trial initiationCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

KHINDIVI

Upcoming / outlook

  • Timing and evidence

Glyburide Oral Suspension

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

ASN-001

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

LIBERVANT

Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ASN-001

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Glyburide Oral Suspension

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

LIBERVANT

Upcoming / outlook

  • Timing and evidence

KHINDIVI

Upcoming / outlook

  • Timing and evidence

Other pipelines

ET-700

Upcoming / outlook

  • Timing and evidence

Mecasermin injection (ET-900)

PreINDP1P3FilingApproved
Upcoming / outlook

Partner / License out

Alpha-adrenergic receptors × Beta-adrenergic receptors

Approved

PreINDP1P2P3FilingApproved

Approved / commercial

Alpha-1 adrenergic receptor

Approved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved
KHINDIVI

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved
Upcoming / outlook

Approved

PreINDP1P2P3FilingApproved

History / paused

Approved

PreINDP1P2P3FilingApproved
ET-700

LIBERVANT

PreINDP1P2P3FilingApproved
LIBERVANT

PreINDP1P2P3FilingApproved
LIBERVANT

PreINDP1P2P3FilingApproved
LIBERVANT

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ETON PR & News

PR & News

ETON SEC archive